Cargando…
Association of serum levels of antibodies against MMP1, CBX1, and CBX5 with transient ischemic attack and cerebral infarction
Transient ischemic attack (TIA) is a predictor for cerebral infarction (CI), and early diagnosis of TIA is extremely important for the prevention of CI. We set out to identify novel antibody biomarkers for TIA and CI, and detected matrix metalloproteinase 1 (MMP1), chromobox homolog 1 (CBX1), and ch...
Autores principales: | Wang, Hao, Zhang, Xiao-Meng, Tomiyoshi, Go, Nakamura, Rika, Shinmen, Natsuko, Kuroda, Hideyuki, Kimura, Risa, Mine, Seiichiro, Kamitsukasa, Ikuo, Wada, Takeshi, Aotsuka, Akiyo, Yoshida, Yoichi, Kobayashi, Eiichi, Matsutani, Tomoo, Iwadate, Yasuo, Sugimoto, Kazuo, Mori, Masahiro, Uzawa, Akiyuki, Muto, Mayumi, Kuwabara, Satoshi, Takemoto, Minoru, Kobayashi, Kazuki, Kawamura, Harukiyo, Ishibashi, Ryoichi, Yokote, Koutaro, Ohno, Mikiko, Chen, Po-Min, Nishi, Eiichiro, Ono, Koh, Kimura, Takeshi, Machida, Toshio, Takizawa, Hirotaka, Kashiwado, Koichi, Shimada, Hideaki, Ito, Masaaki, Goto, Ken-Ichiro, Iwase, Katsuro, Ashino, Hiromi, Taira, Akiko, Arita, Emiko, Takiguchi, Masaki, Hiwasa, Takaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814161/ https://www.ncbi.nlm.nih.gov/pubmed/29464021 http://dx.doi.org/10.18632/oncotarget.23789 |
Ejemplares similares
-
Elevation of autoantibody level against PDCD11 in patients with transient ischemic attack
por: Yoshida, Yoichi, et al.
Publicado: (2017) -
Elevated Adiponectin Antibody Levels in Sera of Patients with Atherosclerosis-Related Coronary Artery Disease, Cerebral Infarction and Diabetes Mellitus
por: Hiwasa, Takaki, et al.
Publicado: (2016) -
Elevated levels of autoantibodies against DNAJC2 in sera of patients with atherosclerotic diseases
por: Yoshida, Yoichi, et al.
Publicado: (2020) -
Identification of the Prognostic Biomarkers CBX6 and CBX7 in Bladder Cancer
por: Li, Xinxin, et al.
Publicado: (2023) -
Single Nucleotide Polymorphisms of CBX4 and CBX7 Decrease the Risk of Hepatocellular Carcinoma
por: Tan, Chao, et al.
Publicado: (2019)